The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia

Benign prostatic hyperplasia (BPH) is one of the most common genitourinary complications in men over 50 years of age and typically presents with lower urinary tract symptoms (LUTS). Classes of medications include α1-adrenoceptor blockers, 5α-reductase inhibitors, and phosphodiesterase 5 inhibitors....

Descripción completa

Detalles Bibliográficos
Autores principales: Gandhi, Jason, Weissbart, Steven J., Smith, Noel L., Kaplan, Steven A., Dagur, Gautam, Zumbo, Anna, Joshi, Gargi, Khan, Sardar Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422692/
https://www.ncbi.nlm.nih.gov/pubmed/28540239
http://dx.doi.org/10.21037/tau.2017.03.57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5422692/
https://www.ncbi.nlm.nih.gov/pubmed/28540239
http://dx.doi.org/10.21037/tau.2017.03.57

Ejemplares similares